Table 1.

Distribution of maternal (in utero exposure) and peripubertal urinary phthalate metabolites and BPA (μg/L, not adjusted for urine dilution)

	LOD	GM	5^th	25^th	50^th	75^th	95^th
In utero (n=116)
MEHP	1.0	5.0	<1.0	2.52	5.63	9.50	30.1
MEHHP	0.1	19.1	3.49	9.13	22.7	37.5	96.7
MEOHP	0.1	11.6	2.45	5.80	13.25	24.7	56.1
MECPP	0.2	30.9	6.12	15.1	35.4	58.1	138
MBzP	0.2	4.1	0.95	2.22	3.67	7.04	29.6
MnBP	0.5	54.3	7.06	26.4	54.2	119	606
MiBP	0.2	2.0	0.34	0.96	2.01	3.62	12.6
MCPP	0.2	1.0	<0.2	0.50	1.07	1.93	6.55
MEP	1.0	114	9.12	40.8	116	242	1900
BPA	0.4	0.78	<0.4	<0.4	0.70	1.42	4.06
Peripubertal (n=129)
MEHP	1.0	5.8	<1.0	3.55	5.49	11.4	19.4
MEHHP	0.1	45.4	11.4	23.9	46.1	86.6	189
MEOHP	0.1	20.0	4.78	11.6	20.3	39	84.5
MECPP	0.2	61.8	14.8	36	67.1	111	213
MBzP	0.2	5.8	1.21	3.36	5.82	10.8	23.5
MnBP	0.5	108	18.3	59.4	109	224	615
MiBP	0.2	10.9	2.85	5.93	11.7	19.1	45
MCPP	0.2	2.2	0.44	1.06	2.45	3.93	13.7
MEP	1.0	97.5	15	32.2	82.9	243	1230
BPA	0.4	1.2	<0.4	0.583	1.3	2.57	5.82

LOD, limit of detection; GM, geometric mean